The Growing Case for Use of SGLT2i in Heart Failure: Additional Benefits of Empagliflozin in a HFpEF Rodent Model

[Figure: see text]

Detalles Bibliográficos
Autores principales: Ha, Chae-Myeong, Wende, Adam R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Editorial Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390674/
https://www.ncbi.nlm.nih.gov/pubmed/30847417
http://dx.doi.org/10.1016/j.jacbts.2019.01.003
_version_ 1783398186050650112
author Ha, Chae-Myeong
Wende, Adam R.
author_facet Ha, Chae-Myeong
Wende, Adam R.
author_sort Ha, Chae-Myeong
collection PubMed
description [Figure: see text]
format Online
Article
Text
id pubmed-6390674
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-63906742019-03-07 The Growing Case for Use of SGLT2i in Heart Failure: Additional Benefits of Empagliflozin in a HFpEF Rodent Model Ha, Chae-Myeong Wende, Adam R. JACC Basic Transl Sci Editorial Comment [Figure: see text] Elsevier 2019-02-25 /pmc/articles/PMC6390674/ /pubmed/30847417 http://dx.doi.org/10.1016/j.jacbts.2019.01.003 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial Comment
Ha, Chae-Myeong
Wende, Adam R.
The Growing Case for Use of SGLT2i in Heart Failure: Additional Benefits of Empagliflozin in a HFpEF Rodent Model
title The Growing Case for Use of SGLT2i in Heart Failure: Additional Benefits of Empagliflozin in a HFpEF Rodent Model
title_full The Growing Case for Use of SGLT2i in Heart Failure: Additional Benefits of Empagliflozin in a HFpEF Rodent Model
title_fullStr The Growing Case for Use of SGLT2i in Heart Failure: Additional Benefits of Empagliflozin in a HFpEF Rodent Model
title_full_unstemmed The Growing Case for Use of SGLT2i in Heart Failure: Additional Benefits of Empagliflozin in a HFpEF Rodent Model
title_short The Growing Case for Use of SGLT2i in Heart Failure: Additional Benefits of Empagliflozin in a HFpEF Rodent Model
title_sort growing case for use of sglt2i in heart failure: additional benefits of empagliflozin in a hfpef rodent model
topic Editorial Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390674/
https://www.ncbi.nlm.nih.gov/pubmed/30847417
http://dx.doi.org/10.1016/j.jacbts.2019.01.003
work_keys_str_mv AT hachaemyeong thegrowingcaseforuseofsglt2iinheartfailureadditionalbenefitsofempagliflozininahfpefrodentmodel
AT wendeadamr thegrowingcaseforuseofsglt2iinheartfailureadditionalbenefitsofempagliflozininahfpefrodentmodel
AT hachaemyeong growingcaseforuseofsglt2iinheartfailureadditionalbenefitsofempagliflozininahfpefrodentmodel
AT wendeadamr growingcaseforuseofsglt2iinheartfailureadditionalbenefitsofempagliflozininahfpefrodentmodel

Ejemplares similares